fda warning letters glp-1 november 2025 october compounding Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse FDA unleashes warning letters to – FDA sends warning letter after

Itching or Tenderness Itching and mild pain are also common injection site reactions with GLP-1s like tirzepatide, semaglutide, or liraglutide

The only scenario where sterile water may be preferred is when benzyl alcohol compatibility is a concern for specific assay systems or cell culture applications where preservative interference must be minimized

The Role of Oral Anti-Diabetic Drugs Oral anti-diabetic drugs remain the most widely used treatment, particularly in cases where lifestyle modifications alone are insufficient

Jardiance, DailyMed (2025) Farxiga, DailyMed (2024) Ozempic, DailyMed (2025) Mounjaro, DailyMed (2025) Januvia, DailyMed (2024) Metformin, DailyMed (2020) Vitamins, minerals, and supplements, American Diabetes Association Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2022 , American Diabetes Association (2021) What can apple cider vinegar really do for your health